Following the 2010 revision of international guidelines redefining the cut-offs for estrogen and progesterone receptor positivity in breast cancer,18 the Swedish Breast Cancer Group (SweBCG) retained the ≥ 10% threshold. The gene discussed is PGR; the disease is breast carcinoma.